Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.35
+0.47 (2.96%)
Oct 30, 2025, 9:55 AM EDT - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $892.91 million as of October 30, 2025. Its market cap has decreased by -17.79% in one year.
Market Cap
892.91M
Enterprise Value
432.88M
1-Year Change
-17.79%
Ranking
Category
Stock Price
$16.35
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $892.91M, a decrease of -4.16%. That is a compound annual growth rate of -3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 867.25M | -8.51% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.21B |
| Johnson & Johnson | 456.85B |
| AbbVie | 401.73B |
| UnitedHealth Group | 329.67B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 218.71B |